Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 51.44M
March 31, 2026 6.164M
December 31, 2025 7.196M
September 30, 2025 5.002M
June 30, 2025 6.048M
March 31, 2025 7.661M
December 31, 2024 10.10M
September 30, 2024 8.901M
June 30, 2024 16.38M
March 31, 2024 19.65M
December 31, 2023 26.14M
September 30, 2023 37.78M
June 30, 2023 48.28M
March 31, 2023 59.71M
Date Value
December 31, 2022 44.04M
September 30, 2022 50.71M
June 30, 2022 61.08M
March 31, 2022 71.10M
December 31, 2021 83.31M
September 30, 2021 98.76M
June 30, 2021 115.27M
March 31, 2021 70.49M
December 31, 2020 84.10M
September 30, 2020 98.08M
June 30, 2020 114.30M
March 31, 2020 130.81M
December 31, 2019 123.38M
September 30, 2019 79.76M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 142.97M
Cue Biopharma, Inc. 30.71M
Yarrow Bioscience, Inc. 23.60M
Faeth Therapeutics, Inc. 178.95M
Immuneering Corp. 182.56M

Total Assets (Quarterly) Related Metrics